Loteprednol etabonate gel 0.5% for postoperative pain and inflammation after cataract surgery: results of a multicenter trial

QR Code

Loteprednol etabonate gel 0.5% for postoperative pain and inflammation after cataract surgery: results of a multicenter trial

Raymond Fong,1 Martin Leitritz,2 Raphaele Siou-Mermet,3 Tara Erb41Manhattan Eye, Ear and Throat Hospital, Lenox Hill Hospital, New York, NY, USA; 2Department of Ophthalmology, University Eye Hospital T&uuml;bingen, University of T&uuml;bingen, T&uuml;bingen, Germany; 3Bausch...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Fong R, Leitritz M, Siou-Mermet R, Erb T
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2012
Sujets:	Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/e09c161566314bc59b2eedc509e926f2
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Safety and efficacy of loteprednol etabonate ophthalmic ointment 0.5% for the treatment of inflammation and pain following cataract surgery
par: Timothy L Comstock, et autres
Publié: (2011)

A retrospective analysis of the postoperative use of loteprednol etabonate gel 0.5% following laser-assisted in situ keratomileusis or photorefractive keratectomy surgery
par: Salinger CL, et autres
Publié: (2015)

Development of a non-settling gel formulation of 0.5% loteprednol etabonate for anti-inflammatory use as an ophthalmic drop
par: Coffey MJ, et autres
Publié: (2013)

Dose uniformity of loteprednol etabonate ophthalmic gel (0.5%) compared with branded and generic prednisolone acetate ophthalmic suspension (1%)
par: Marlowe ZT, et autres
Publié: (2013)

A retrospective analysis of the use of loteprednol etabonate ophthalmic suspension 0.5% following canaloplasty
par: Khaimi MA
Publié: (2018)

Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies
par: Fong R, et autres
Publié: (2019)

Real world use of loteprednol etabonate ophthalmic gel 0.5% in cases representative of comorbid pathologies responding to minimally invasive glaucoma surgery
par: Sheppard JD, et autres
Publié: (2019)

Efficacy and safety of a 3-month loteprednol etabonate 0.5% gel taper for routine prophylaxis after photorefractive keratectomy compared to a 3-month prednisolone acetate 1% and fluorometholone 0.1% taper
par: Mifflin MD, et autres
Publié: (2017)

An update on the surgical management of pterygium and the role of loteprednol etabonate ointment
par: Sheppard JD, et autres
Publié: (2014)

Critical appraisal of loteprednol ointment, gel, and suspension in the treatment of postoperative inflammation and pain following ocular and corneal transplant surgery
par: Pirouzian A, et autres
Publié: (2014)

Tetracaine 0.5% eyedrops with or without lidocaine 2% gel in topical anesthesia for cataract surgery
par: Anthoula T Tsoumani, et autres
Publié: (2010)

Difluprednate ophthalmic emulsion 0.05% (Durezol&reg;) administered two times daily for managing ocular inflammation and pain following cataract surgery
par: Stephen Smith, et autres
Publié: (2010)

Antibacterial efficacy of prophylactic besifloxacin 0.6% and moxifloxacin 0.5% in patients undergoing cataract surgery
par: Bucci FA Jr, et autres
Publié: (2015)

A prospective study on postoperative pain after cataract surgery
par: Porela-Tiihonen S, et autres
Publié: (2013)

Difluprednate 0.05% versus Prednisolone Acetate Post-Phacoemulsification for Inflammation and Pain: An Efficacy and Safety Clinical Trial
par: Palacio-Pastrana C, et autres
Publié: (2020)

Efficacy and safety of 0.5% levobupivacaine versus 0.5% bupivacaine for peribulbar anesthesia
par: Pacella E, et autres
Publié: (2013)

Pharmacokinetics and aqueous humor penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing cataract surgery
par: Bucci Jr FA, et autres
Publié: (2016)

Preparation and characterization of a new graphite superconductor: Ca0.5Sr0.5C6
par: Saki Nishiyama, et autres
Publié: (2017)

Light-induced enhancement of superconductivity in iron-based superconductor FeSe0.5Te0.5
par: Kazuki Isoyama, et autres
Publié: (2021)

Li(V0.5Ti0.5)S2 as a 1 V lithium intercalation electrode
par: Steve J. Clark, et autres
Publié: (2016)

Magnetic breakdown in 2D hole system at GaAs/Al0.5Ga0.5As heterointerface
par: Minina, N., et autres
Publié: (2005)

Photoconductivity in p-GaAs/Al0.5Ga0.5As and deep donor like states at heterointerface
par: Bogdanov, E., et autres
Publié: (2005)

Effect Of Intracameral Phenylephrine And Ketorolac 1.0%/0.3% On Intraoperative Pain And Opioid Use During Cataract Surgery
par: Donnenfeld ED, et autres
Publié: (2019)

Effect of heparin in the intraocular irrigating solution on postoperative inflammation in the pediatric cataract surgery
par: Yelda B &Ouml;zkurt, et autres
Publié: (2009)

Use of loteprednol for routine prophylaxis after photorefractive keratectomy
par: Moshirfar M, et autres
Publié: (2012)

A retrospective analysis of intraocular pressure changes after cataract surgery with the use of prednisolone acetate 1% versus difluprednate 0.05%
par: Kusne Y, et autres
Publié: (2016)

Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy
par: Schnober D, et autres
Publié: (2015)

Influence on ocular surface after cataract surgery and effect of topical diquafosol on postoperative dry eye: a multicenter prospective randomized study
par: Miyake K, et autres
Publié: (2017)

Multicenter study of the effectiveness of postoperative pain relief in Ukraine using paracetаmol in surgical hospitals – “ROZUM”
par: Dmytro Dmitriev, et autres
Publié: (2021)

Thick Film Ni0.5Mn0.5−xSnx Heusler Alloys by Multi-layer Electrochemical Deposition
par: Yijia Zhang, et autres
Publié: (2018)

High-temperature poling treatment of congruent ferroelectric LiNb0.5Ta0.5O3 solid solution single crystals
par: Anatolii A. Mololkin, et autres
Publié: (2021)

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
par: Inoue K, et autres
Publié: (2015)

Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study
par: Pillunat LE, et autres
Publié: (2017)

Optical properties of some [(As2S3)0.5:(As2Se3)0.5]1-x:Snx chalcogenide glasses
par: Iaseniuc, Oxana
Publié: (2012)

Green synthesis, characterization and anti-cancer capability of Co0.5Ni0.5Nd0.02Fe1.98O4 nanocomposites
par: M.A. Almessiere, et autres
Publié: (2022)

Managing refractory glaucoma with a fixed combination of bimatoprost (0.03%) and timolol (0.5%)
par: Moataz E Gheith, et autres
Publié: (2008)

Achieving a high dielectric tunability in strain-engineered tetragonal K0.5Na0.5NbO3 films
par: Lanxia Hao, et autres
Publié: (2021)

Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
par: Kanamoto T, et autres
Publié: (2012)

Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension
par: Baiza-Dur&aacute;n LM, et autres
Publié: (2012)

Anisotropy of Percolation Threshold of BaTiO3-Ni0.5Zn0.5Fe2O4 Composite Films
par: Yu Tang, et autres
Publié: (2019)